ETHEX Corporation Initiated Nationwide Voluntary Recall of a Single Lot of Hydromorphone HCl 2 mg Tablets Due to Potential for Oversized Tablet

Contact:
Ann McBride
1-800-748-1472

FOR IMMEDIATE RELEASE – St. Louis, MO – December 23, 2008 – ETHEX Corporation announced today that it has voluntarily recalled to the consumer level, a single production lot of Hydromorphone HCl 2 mg tablets (Lot #90219, Exp: 03/2010; NDC #58177-0620-04), as a precaution, due to the possibility it may contain oversized tablets. Hydromorphone is a drug used for pain management and is packaged under the ETHEX label in 100-count bottles.

If someone were to take a higher than expected dose of Hydromorphone, the risk of adverse effects known to be associated with the drug may be increased, including respiratory depression (difficulty or lack of breathing), low blood pressure, and sedati

Read More

If you have been seriously injured by the above event, please visit the products liability lawyers at Masry & Vititoe for a case evaluation. Through experience and education, Masry and Vititoe is able to expertly evaluate medical injuries and pursue personal injury claims on behalf of the injured plaintiff.